Times are stated in CEST (GMT + 2 / UTC + 2)
Every effort has been made to convert the IPVC 2020 scientific program into a fully virtual program. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive program on the virtual conference platform. Please note that some presenters were not able to pre-record their presentations, therefore there are still some sessions with missing presentations.
To view the pre-conference workshops, you need to register for them separately. Please contact: reg_ipvc20@kenes.com
You will then receive an email with instructions on how to login to the workshops’ platform.
Public Health Oral Session
Session Type
Public Health Oral Session
Session Date
07/22/2020
Session Time
08:45 - 09:45
Room
Hall E
Session Webcast
Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening
Hall E
EFFECTIVENESS OF ORGANISED PRIMARY HPV-BASED CERVICAL SCREENING OF WOMEN AGE 30-64: RANDOMISED HEALTHCARE POLICY (ID 958)
Session Date
07/22/2020
Session Time
08:45 - 09:45
Room
Hall E
Session Type
Public Health Oral Session
Lecture Time
08:45 - 08:57
Presenter
Webcast
Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening
Hall E
THE POSITIVE PREDICTIVE VALUE OF HPV TESTING VARIES WITH AGE AND REFLEX CYTOLOGY: FOLLOW-UP RESULTS FROM THE FIRST ROUND OF HPV PRIMARY SCREENING (ID 721)
Session Date
07/22/2020
Session Time
08:45 - 09:45
Room
Hall E
Session Type
Public Health Oral Session
Lecture Time
08:57 - 09:09
Presenter
Webcast
Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening
Hall E
IMPACT OF CERVICITIS ON PERFORMANCE OF PRIMARY HIGH RISK HPV TESTING FOLLOWED BY VISUAL EVALUATION IN WOMEN LIVING WITH HIV (ID 573)
Session Date
07/22/2020
Session Time
08:45 - 09:45
Room
Hall E
Session Type
Public Health Oral Session
Lecture Time
09:09 - 09:21
Presenter
Webcast
Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening
Hall E
PERFORMANCE COMPARISON AMONG CERVICAL, VAGINAL AND URINE SAMPLES IN CERVICAL CANCER SCREENING IN CHINA (ID 876)
Session Date
07/22/2020
Session Time
08:45 - 09:45
Room
Hall E
Session Type
Public Health Oral Session
Lecture Time
09:21 - 09:33
Presenter
Authors
Webcast
Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening
Hall E
DISCRETE EVENT SIMULATION MODELS TO SUPPORT RESOURCE AND OPERATIONAL PLANNING OF CERVICAL CANCER SCREENING PROGRAMS: A PILOT STUDY IN PERU (ID 434)
Session Date
07/22/2020
Session Time
08:45 - 09:45
Room
Hall E
Session Type
Public Health Oral Session
Lecture Time
09:33 - 09:45
Webcast
Oral Session 4: SCREENING II. Evaluation and impact of cervical cancer screening
Hall E
Online Chat Q&A for this session is called: PUBLIC HEALTH ORAL SESSION 4: SCREENING II. EVALUATION AND IMPACT OF CERVICAL CANCER SCREENING. You can join the online chat Q&A and discussions for this session by going back to the Lobby and entering the Networking Lounge. Speakers are encouraged to be online in the chat room at the time this session is stated to end. All times are in CEST. (ID 1819)
Session Date
07/22/2020
Session Time
08:45 - 09:45
Room
Hall E
Session Type
Public Health Oral Session
Lecture Time
09:45 - 09:45